drugset / Trial / NCT01242618

Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule

NCT01242618 ↗

Phase 1 Completed 5 enrolled University Hospital, Basel, Switzerland
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the safety and feasibility of implanting an engineered cartilage graft, obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane, in the alar lobule of patients after resection of a non melanoma skin cancer.

Timeline

Start
2010-10
Primary completion
2013-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject engineered nasal cartilage graft Cell therapy — Other

Indications